{"id":"W2154197604","doi":"10.1093/annonc/mds581","title":"Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"BC Cancer Agency; State Key Laboratory of Oncology in South China; Bayer Corporation","keywords":"Medicine; Nasopharyngeal carcinoma; Fluorouracil; Sorafenib; Cisplatin; Oncology; Internal medicine; Carcinoma; Chemotherapy; Radiation therapy; Hepatocellular carcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002190341,0.002249959,0.004880158,0.0008928715,0.0006678387,0.001603995,0.00188475,0.001466118,0.004702426],"category_scores_gemma":[0.001193765,0.001367162,0.002396082,0.0007904521,0.001765692,0.001564042,0.0005416942,0.004433239,0.001321658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001453386,"about_ca_system_score_gemma":0.002929715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003195487,"about_ca_topic_score_gemma":0.006904008,"domain_scores_codex":[0.9993211,0.0003075757,0.00003618444,0.0001212738,0.00005125132,0.0001625927],"domain_scores_gemma":[0.9990659,0.0001416472,0.0001273277,0.00009233699,0.00006476502,0.0005079935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8028341,0.09022387,0.002625321,0.0012311,0.002341584,0.0002871401,0.0005154736,0.004475564,0.02597339,0.0004394494,0.003402128,0.06565095],"study_design_scores_gemma":[0.6418235,0.3490446,0.003075655,0.00002978847,0.0005667703,0.0001398118,0.0001084442,0.001085654,0.00234172,0.0001318642,0.001612802,0.00003934681],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925165,0.001935973,0.0005555369,0.0004594446,0.0002813359,0.002191986,0.0006560723,0.0001073386,0.00129597],"genre_scores_gemma":[0.98912,0.002700455,0.001291255,0.0004141231,0.0002138764,0.002118018,0.001237852,0.0000465063,0.00285798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004880158,"threshold_uncertainty_score":0.01573116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1562041069770062,"score_gpt":0.4409741329131073,"score_spread":0.2847700259361012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}